{"id":789715,"date":"2026-03-10T21:20:18","date_gmt":"2026-03-10T21:20:18","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/789715\/"},"modified":"2026-03-10T21:20:18","modified_gmt":"2026-03-10T21:20:18","slug":"une-decouverte-majeure-de-chercheurs-francais-ouvre-des-pistes-de-traitement","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/789715\/","title":{"rendered":"Une d\u00e9couverte majeure de chercheurs fran\u00e7ais ouvre des pistes de traitement"},"content":{"rendered":"<p>La recherche sur la maladie d\u2019Alzheimer et son traitement progresse. Une \u00e9quipe fran\u00e7aise du CHU de <a href=\"https:\/\/www.20minutes.fr\/lille\/\" class=\"c-link c-link--is-underlined\" rel=\"nofollow noopener\" target=\"_blank\">Lille <\/a>et de<a href=\"https:\/\/presse.inserm.fr\/alzheimer-decouverte-de-limplication-de-nouvelles-cellules-dans-lapparition-et-la-progression-de-la-maladie\/72092\/\" target=\"_blank\" class=\"c-link c-link--is-underlined\" rel=\"nofollow noopener\"> l\u2019Inserm<\/a> dirig\u00e9e par le docteur Vincent Pr\u00e9vot vient de comprendre un m\u00e9canisme jusque-l\u00e0 inconnu dans le fonctionnement et le d\u00e9veloppement de la maladie d\u2019<a href=\"https:\/\/www.20minutes.fr\/dossier\/alzheimer\" class=\"c-link c-link--is-underlined\" rel=\"nofollow noopener\" target=\"_blank\">Alzheimer<\/a>.<\/p>\n<p>Les r\u00e9sultats de leur \u00e9tude publi\u00e9e dans la revue <a href=\"https:\/\/www.cell.com\/cell-press-blue\/fulltext\/S3051-3839(26)00001-0\" target=\"_blank\" class=\"c-link c-link--is-underlined\" rel=\"nofollow noopener\">Cell Press Blue<\/a>, montre que l\u2019accumulation de prot\u00e9ines de Tau, marqueur de la neurod\u00e9g\u00e9n\u00e9rescence, est due \u00e0 un d\u00e9faut de fonctionnement des tanycytes, des petites cellules c\u00e9r\u00e9brales charg\u00e9es de leur \u00e9vacuation.<\/p>\n<p>M\u00e9dicament, pr\u00e9vention, des pistes de traitements<\/p>\n<p>Cette d\u00e9couverte est porteuse d\u2019espoir quant \u00e0 la mise au point d\u2019un traitement par <a href=\"https:\/\/www.20minutes.fr\/dossier\/medicament\" class=\"c-link c-link--is-underlined\" rel=\"nofollow noopener\" target=\"_blank\">m\u00e9dicament <\/a>de cette d\u00e9faillance, alors que la maladie d\u2019Alzheimer reste \u00e0 ce jour incurable. Il devient aussi alors possible d\u2019essayer de comprendre comment pr\u00e9venir le dysfonctionnement de nos tanycytes.<\/p>\n<p>Environ 900.000 Fran\u00e7ais sont atteints de la maladie d\u2019Alzheimer, qui touche particuli\u00e8rement les personnes de plus de 65 ans.<\/p>\n","protected":false},"excerpt":{"rendered":"La recherche sur la maladie d\u2019Alzheimer et son traitement progresse. Une \u00e9quipe fran\u00e7aise du CHU de Lille et&hellip;\n","protected":false},"author":2,"featured_media":789716,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[10],"tags":[47,772,1011,27,811,72,4281,1307,226,225,1308,1309,71,227],"class_list":["post-789715","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sante","tag-actualite","tag-alzheimer","tag-fr","tag-france","tag-hauts-de-france","tag-health","tag-inserm","tag-lille","tag-maladie","tag-medicament","tag-nord","tag-nord-pas-de-calais","tag-sante","tag-traitement"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/116206975513713255","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/789715","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=789715"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/789715\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/789716"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=789715"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=789715"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=789715"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}